se asia

新闻24 | “金鹅有翅膀”：百万富翁威胁因税收问题放弃英国定居意向 News24 | ‘Golden geese have wings’: Millionaires threaten to desert UK over tax 作者： fin24 LONDON, July 19 – For ultra-wealthy entrepreneur Bassim Haidar, living in London has become an expensive indulgence he can no longer justify. 伦敦，7月19日 – 对于超级富豪企业家巴希姆·海达尔来说，住在伦敦已经成为他无法再为之辩护的昂贵放纵。 For ultra-wealthy entrepreneur Bassim Haidar, living in London has become an expensive … Read more

新加坡的海洋和近海公司探索海外市场，以抓住风能机遇。 Singapore’s marine and offshore firms explore overseas markets to seize wind energy opportunities 作者： None Singapore maritime companies are offering their expertise in countries as far-flung as Scotland. 新加坡的海事公司在遥远如苏格兰的国家提供他们的专业知识。 By 2030, the international offshore wind industry is set to be worth about US$126 billion. Key growth markets include the United States, Europe, South Korea, … Read more

分析——地缘政治回归，打破市场步伐。 Analysis-Geopolitics is back to break markets’ stride 作者： Laura Matthews and Tom Westbrook Politics has toppled global markets from record peaks and over a turbulent few weeks stepped to the fore as investors confront the prospect of an… 政治因素已将全球市场从历史高点拉下，在经历了几周的动荡之后，投资者面对前景时，政治因素日益凸显。 By Laura Matthews and Tom Westbrook NEW YORK/SINGAPORE (Reuters) – Politics has toppled global markets … Read more

STADA和Alvotech在欧洲推出Uzpruvo，这是首个获得批准的针对Stelara的乌司奴单抗生物类似药。 STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe 作者： Alvotech STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe Launch of European-made Uzpruvo in Europe… STADA和Alvotech在欧洲推出Uzpruvo，这是首个获得批准的针对Stelara的ustekinumab生物类似药。在欧洲推出欧洲制造的Uzpruvo… STADA and Alvotech launch Uzpruvo, the first approved ustekinumab biosimilar to Stelara, across Europe Launch of European-made … Read more